Search results for "cancer diagnosis"

The test could offer clinicians a specific, quantitative diagnostic and prognostic solution to help prioritize the treatment of sepsis

Plitek will be showcasing its commitment to delivering tailored solutions to diagnostics and medical device companies at Booth #4843.

Explore innovations and tools for clinical labs shaping the future of sepsis management, clinical mass spec, anticoagulant diagnostics, and more

Designed with one of the most advanced software packages on the market, the ADVIA Centaur XPT System is among the highest-throughput systems available. The ADVIA Centaur XPT System delivers the results that clinicians depend upon for accurate diagnoses and better patient care—and does so predictably and consistently. Siemens unites innovative workflow solutions with clinical excellence in the ADVIA Centaur XPT System, leading…

New clinical insights reveal how this protein helps diagnose, monitor, and predict flare-ups in rheumatic diseases

PerfeCTa qPCR ToughMix is intended for molecular biology applications. This product is not intended for the diagnosis, prevention or treatment of a disease.

Funds will aid in the completion of its upper respiratory panel multiplex on Co-Dx PCR Home platform

Raptor Diagnostic Reader

David Wells, Chief Executive of IBMS and CLINICAL24 Ambassador, shares insights on tackling diagnostic challenges and optimizing the biomedical science workforce

Uncover the remarkable evolution of point-of-care diagnostics as we examine the significant breakthroughs achieved over the years and explore exciting future directions

Discover the latest tools and techniques to expand your work in clinical diagnostics with expert-led presentations on high-throughput routine diagnostics, strategies for syndromic testing, point-of-care testing in pediatrics, and much more

Multiplex molecular testing for plant pathogens

New initiative aims to incentivize the use of standard protocols for assessing and comparing diffuse optics systems in medical diagnosis

Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR

New capsid free antigen overcomes cross-reactivity difficulties, reducing the likelihood of false positives